Clinical Applications of Molecular Biomarkers in Prostate Cancer

Clinical Applications of Molecular Biomarkers in Prostate Cancer

There<b> </b>is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological diversity has had only a minimal impact on clinical practice. Treatment outcomes in patients with localised PCa are often highly variable, even among patients stratified to the same...

Full description

Bibliographic Details
Main Authors: Felipe Couñago, Fernando López-Campos, Ana Aurora Díaz-Gavela, Elena Almagro, Esaú Fenández-Pascual, Iván Henríquez, Rebeca Lozano, Estefanía Linares Espinós, Alfonso Gómez-Iturriaga, Guillermo de Velasco, Luis Miguel Quintana Franco, Ignacio Rodríguez-Melcón, José López-Torrecilla, Daniel E. Spratt, Luis Leonardo Guerrero, Juan Ignacio Martínez-Salamanca, Elia del Cerro
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
biomarkers
DNA repair
gene panels
genetic testing
germline mutation
precision medicine
Online Access:https://www.mdpi.com/2072-6694/12/6/1550

Internet

https://www.mdpi.com/2072-6694/12/6/1550

Similar Items